Division of Epidemiology & Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
Division of Hematology/Oncology, Department of Pediatrics, University of Miami, Miami, FL, USA.
JNCI Cancer Spectr. 2022 Mar 2;6(2). doi: 10.1093/jncics/pkac020.
Pediatric cancer incidence has steadily increased concurrent with rising adult obesity, but associations between maternal obesity and associated comorbidities and pediatric cancer risk remain understudied. We aimed to quantitatively characterize associations of pediatric cancer risk with maternal prepregnancy body mass index (BMI), gestational weight gain, and maternal diabetes.
We performed a comprehensive and systematic literature search in Ovid and EMBASE from their inception to March 15, 2021. Eligible studies reported risk estimates and sample sizes and provided sufficient description of outcome and exposure ascertainment. Random effects models were used to estimate pooled effects.
Thirty-four studies were included in the analysis. Prepregnancy BMI was positively associated with leukemia risk in offspring (odds ratio [OR] per 5-unit BMI increase =1.07, 95% confidence intervals [CI] = 1.04 to 1.11; I2 = 0.0%). Any maternal diabetes was positively associated with acute lymphoblastic leukemia risk (OR = 1.46, 95% CI = 1.28 to 1.67; I2 = 0.0%), even after restricting to birthweight-adjusted analyses (OR = 1.74, 95% CI = 1.29 to 2.34; I2 = 0.0%), and inversely associated with risk of central nervous system tumors (OR = 0.73, 95% CI = 0.55 to 0.97; I2 = 0.0%). Pregestational diabetes (OR = 1.57, 95% CI = 1.11 to 2.24; I2 = 26.8%) and gestational diabetes (OR = 1.40, 95% CI = 1.12 to 1.75; I2 = 0.0%) were also positively associated with acute lymphoblastic leukemia risk. No statistically significant associations were observed for gestational weight gain.
Maternal obesity and diabetes may be etiologically linked to pediatric cancer, particularly leukemia and central nervous system tumors. Our findings support weight management and glycemic control as important components of maternal and offspring health. Further validation is warranted.
儿科癌症的发病率随着成人肥胖率的上升而稳步上升,但母亲肥胖症及其相关合并症与儿科癌症风险之间的关联仍研究不足。我们旨在定量描述儿科癌症风险与母亲孕前体重指数(BMI)、妊娠期体重增加和母亲糖尿病之间的关系。
我们在 Ovid 和 EMBASE 中进行了全面而系统的文献检索,检索时间从成立到 2021 年 3 月 15 日。符合条件的研究报告了风险估计值和样本量,并对结局和暴露的确定提供了充分的描述。使用随机效应模型来估计汇总效应。
共有 34 项研究纳入分析。孕前 BMI 与后代白血病风险呈正相关(每增加 5 个单位 BMI 的比值比 [OR] =1.07,95%置信区间 [CI] = 1.04 至 1.11;I2 = 0.0%)。任何类型的母亲糖尿病都与急性淋巴细胞白血病风险呈正相关(OR = 1.46,95%CI = 1.28 至 1.67;I2 = 0.0%),即使在限制到与出生体重相关的分析后(OR = 1.74,95%CI = 1.29 至 2.34;I2 = 0.0%),也与中枢神经系统肿瘤风险呈负相关(OR = 0.73,95%CI = 0.55 至 0.97;I2 = 0.0%)。孕前糖尿病(OR = 1.57,95%CI = 1.11 至 2.24;I2 = 26.8%)和妊娠期糖尿病(OR = 1.40,95%CI = 1.12 至 1.75;I2 = 0.0%)也与急性淋巴细胞白血病风险呈正相关。妊娠期体重增加与儿科癌症风险之间没有统计学显著关联。
母亲肥胖和糖尿病可能与儿科癌症,特别是白血病和中枢神经系统肿瘤的发生有因果关系。我们的研究结果支持将体重管理和血糖控制作为母婴健康的重要组成部分。还需要进一步验证。